US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist
  • 1.2100
  • +0.0300+2.54%
Trading Jan 3 09:30 ET
7.13MMarket Cap-0.51P/E (TTM)

Plus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Plus Therapeutics Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
EPS
-0.56
-0.37
+0.19
Beat Est.
+43.75%
+63.00%
+34.21%
Net Income
--
-2.87M
--
+10.72%
Analyst Rating
Strong Buy

Jan 3, 2025

Plus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.733M--
--2024/Q4-- / 1.193M--
Nov 14, 20242024/Q31.456M / 1.137M--
Aug 14, 20242024/Q21.279M / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.733M--
--2024/Q4-- / 1.193M--
Nov 14, 20242024/Q31.456M / 1.137M--
Aug 14, 20242024/Q21.279M / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--

Unlock Free Earnings Estimates

Plus Therapeutics Earnings Reports

  • Plus Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 15, 2024 06:14

  • Plus Therapeutics | 8-K: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 15, 2024 05:18

  • Plus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 15, 2024 04:36

  • Plus Therapeutics | 8-K: Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 15, 2024 04:11

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 3, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data